4.8 Editorial Material

Differentiation therapy for IDH1/2 mutant malignancies

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

(R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible

Julie-Aurore Losman et al.

SCIENCE (2013)

Article Multidisciplinary Sciences

IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics

Masato Sasaki et al.

NATURE (2012)

Review Oncology

The role of mutations in epigenetic regulators in myeloid malignancies

Alan H. Shih et al.

NATURE REVIEWS CANCER (2012)

Review Biochemistry & Molecular Biology

IDH mutations in glioma and acute myeloid leukemia

Lenny Dang et al.

TRENDS IN MOLECULAR MEDICINE (2010)